gastric juice protein is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-10-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentadecapeptide | Composed of fifteen amino acid residues |
| Amino acid sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Single-letter form GEPPPGKPADDAGLV |
| Original source | Fragment of a protein in human gastric juice | First characterized in the 1990s |
| Number in name | 157 | Refers to the fragment's position in the source protein |
| Human trial evidence | Limited | Preclinical rodent data predominate |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
== Vorkommen == Arsentrioxid entsteht bei der Verbrennung von elementarem Arsen an der Luft. In mineralischer Form kommt Arsenik als kubischer Arsenolith (Arsenikblüte), bestehend aus As4O6- Molekülen analog zu der Struktur von P4O6, sowie als monokliner Claudetit vor.
Das Arsentrioxid entweicht dabei als flüchtiger Hüttenrauch. In langen Kanälen (Giftfängen) verdichtet sich das Gas zu einem weißen Pulver. Die Reinigung des Rohproduktes erfolgt durch Sublimation. Je nach Kondensationstemperatur erhält man ein weißes Pulver, das als Giftmehl bezeichnet wird, oder das farblose, glasartige Arsenikglas. Die Herstellung von reinem Arsentrioxid aus dem Rohprodukt gelingt mit der Umsetzung zum Arsen(III)-chlorid und dessen weiterer Hydrolyse.
== Heutige Verwendung == Arsentrioxid wird zur Herstellung von Giften gegen Nagetiere und Insekten ebenso genutzt wie für die Konservierung von Fellen und Häuten (→ Taxidermie). In der Glasherstellung nutzt man es zum Läutern und Entfärben der Schmelze. Daneben ist Arsentrioxid bereits seit der Antike als wirksames Mittel bei Blutkrankheiten und Syphilis bekannt. In Europa hat es heute den Status eines Orphan-Arzneimittels und wird unter dem Handelsnamen Trisenox (Hersteller Teva) zur Behandlung der akuten Promyelozytenleukämie (APL), einer Unterform der akuten myeloischen Leukämie, eingesetzt. Weiterhin wird es als Arsenicum album in der Homöopathie verwendet und ist eine Urtitersubstanz nach Arzneibuch.
Sources: de.wikipedia.org
Arsentrioxid ist ein starkes Gift und eindeutig krebserregend. Oral aufgenommen können bereits weniger als 0,1 g tödlich sein. Die Giftwirkung beruht auf der Störung mehrerer Prozesse. Unter anderem wird der Aufbau energiereicher Phosphorverbindungen und damit der Energiestoffwechsel gehemmt. Es werden mehrere intrazelluläre Signalübermittlungswege und Enzyme sowie Transportvorgänge an den Membranen durch Inaktivierung von Rezeptoren gestört. Für die krebserregende Wirkung ist die Hemmung von Reparaturmechanismen und die Inaktivierung von sogenannten Tumor-Repressor-Proteinen verantwortlich. Akute Vergiftungen äußern sich nach wenigen Stunden durch massive Durchfälle und Erbrechen. Starke Schmerzen kommen hinzu, zunächst im Magen-Darm-Bereich, später, nach einer Scheinbesserung, treten in den Extremitäten Krämpfe auf. Die körperliche Schwäche nimmt beständig zu, Bewusstseinsstörungen, Sehstörungen und langsames Erkalten können bereits einen Tag vor Eintritt des Todes registriert werden. Bei der Obduktion findet man u. a. erbsen- bis bohnengroße Magenerosionen an der Magenhinterwand, wo die Giftkristalle an der Schleimhaut haften geblieben waren. Um Unfällen vorzubeugen, ist beim Umgang mit dieser Verbindung unter einem Abzug zu arbeiten. Als Gegenmaßnahme bei Vergiftungen ist der Mund auszuspülen, Erbrechen auszulösen (nicht bei bewusstlosen Personen) und sofort ein Arzt zu benachrichtigen. Trotz der hohen Giftigkeit wurde Arsenik im 19. Jahrhundert von Arsenikessern auch als Stimulans gebraucht (Siehe oben).
Sources: de.wikipedia.org
It is a chain of fifteen amino acids, referred to as a pentadecapeptide. The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a fragment of a protein found in human gastric juice.
It is neither a naturally circulating hormone nor an approved medicine in most countries. It is a synthetic peptide fragment used chiefly as a laboratory research material. Its regulatory status varies by jurisdiction, and it is not authorized as a therapeutic product in the United States or the European Union.
Published human evidence is very limited. Most findings come from rodent studies conducted by a small number of groups. As a result, statements about its effects in humans are generally described as uncertain rather than established.
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.